These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 13822363)

  • 1. [Value of a vasodilator derived from beta-phenylethylamine in vascular pathology].
    FERRAND M; ROUMAGNAC H; EHRHART C
    Alger Medicale; 1959 Oct; 63():961-6. PubMed ID: 13822363
    [No Abstract]   [Full Text] [Related]  

  • 2. [Vasodilator treatment with a derivative of beta-phenylethylamine. Results in 5 cases of arterial syndromes].
    DULAC JF; MANY P; PICARD P
    Presse Med (1893); 1959 Sep; 67():1546-7. PubMed ID: 13818551
    [No Abstract]   [Full Text] [Related]  

  • 3. [N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-propylamine, a new synthetic substance for the treatment, from the etiopathogenic viewpoint, of myocardiopathies caused by coronary insufficiency].
    PICCINELLI O
    Farmaco Prat; 1961 Dec; 16():617-25. PubMed ID: 14038347
    [No Abstract]   [Full Text] [Related]  

  • 4. [CONSIDERATIONS ON THE ACTIVITY OF A VASODILATOR: 1-(P-HYDROXYPHENYL)-2-(1-METHYL-2-PHENOXYETHYLAMINE)-PROPANOL-1-HYDROCHLORIDE (DUVADILAN)].
    ANFOSSI F; GUARRAGGI A
    Minerva Cardioangiol; 1964 Mar; 12():123-7. PubMed ID: 14142071
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapeutic trial of a vasodilator in arteriopathy of the extremities. Evaluation of results and discussion on the use of vasodilators in arteritis].
    PIERRON J
    Mars Med; 1960; 97():641-5. PubMed ID: 14432867
    [No Abstract]   [Full Text] [Related]  

  • 6. [First notes on the use of a new vasodilator, Caa 40, in leg ulcers].
    DUGOIS P; COLOMB L; GAGNAIRE J
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():213-4. PubMed ID: 13818502
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new vasodilator in the functional therapy of peripheral arteriopathies: 1-(p-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-propanol HC1].
    FERRANTE G; GRASS IM; NEGRO G
    Minerva Cardioangiol; 1960 Jun; 8():288-95. PubMed ID: 13822372
    [No Abstract]   [Full Text] [Related]  

  • 8. [A new arterial vasodilator: duvadilan].
    CASTRO CM; GROIS M; GRILLI H
    Prensa Med Argent; 1959 Oct; 46():2459-66. PubMed ID: 13808336
    [No Abstract]   [Full Text] [Related]  

  • 9. [Importance of a new synthetic vasodilator, Caa 40, in the treatment of chronic ulcers of the lower extremities].
    THIERS H; COLOMB D; FAYOLLE J; ARCADIO F; NOVE JOSSERAND
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():217-21. PubMed ID: 13837804
    [No Abstract]   [Full Text] [Related]  

  • 10. [Experimental studies on the effect of vasodilatating sympathomimetics with critical observations on the medicinal therapy of the Raynaud's disease].
    SCHULZE W
    Klin Wochenschr; 1954 Dec; 32(45-46):1073-8. PubMed ID: 13234282
    [No Abstract]   [Full Text] [Related]  

  • 11. Observations on the coronary vasodilator effect of 'persantin'.
    PEEL AA; BLUM K; LANCASTER WM; DALL JL; CHALMERS GL
    Scott Med J; 1961 Sep; 6():403-10. PubMed ID: 13733892
    [No Abstract]   [Full Text] [Related]  

  • 12. [Observations on a new synthetic coronary vasodilator].
    TRALDI A; TINCANI GP
    Minerva Med; 1962 Jun; 53():1747-50. PubMed ID: 13922271
    [No Abstract]   [Full Text] [Related]  

  • 13. [The use of a pyrimido-pyrimidine derivative as coronary vasodilator in clinical practice].
    BENITO SENDIN M; ALVAREZ SANCHEZ E
    Medicina (Madr); 1961 Oct; 29():469-82. PubMed ID: 13867248
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the therapy of coronary insufficiency].
    DUETSCH L
    Ther Ggw; 1960 May; 99():228-34. PubMed ID: 13818454
    [No Abstract]   [Full Text] [Related]  

  • 15. [A contribution to the therapy of coronary insufficiency].
    LEIMGARDT H
    Medizinische; 1959 Dec; No 49():2408-12. PubMed ID: 14415455
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical study of a synthetic coronary vasodilator, L 2329].
    JORIS H; SCHMETZ J
    Rev Med Liege; 1961 Sep; 16():486-9. PubMed ID: 13790720
    [No Abstract]   [Full Text] [Related]  

  • 17. [Contribution to the study of a pyrimido-pyrimidine derivative].
    LOPEZ MERINO V; ALGARRA GONZALEZ F; PONS ESPANA E
    Med Esp; 1961 Sep; 46():204-13. PubMed ID: 14466606
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies with a new coronary vasodilator drug: persantin.
    KINSELLA D; TROUP W; McGREGOR M
    Am Heart J; 1962 Feb; 63():146-51. PubMed ID: 14456202
    [No Abstract]   [Full Text] [Related]  

  • 19. [A contribution to the therapy of coronary circulatory disorders].
    BAMBOR HJ
    Med Klin; 1960 Jun; 55():1155-61. PubMed ID: 13796348
    [No Abstract]   [Full Text] [Related]  

  • 20. [Criteria of the efficacy of the treatment of coronary disease: "the coronary vasodilators"].
    CLOAREC M
    Sem Hop Ther Paris; 1961 Oct; 37():753-4. PubMed ID: 13879970
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.